| 15.6 0.08 (0.52%) | 09-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 20.08 | 1-year : | 23.46 |
| Resists | First : | 17.2 | Second : | 20.08 |
| Pivot price | 15.9 |
|||
| Supports | First : | 14.46 |
Second : | 12.77 |
| MAs | MA(5) : | 16.02 |
MA(20) : | 15.4 |
| MA(100) : | 11.98 |
MA(250) : | 12.4 |
|
| MACD | MACD : | 0.8 |
Signal : | 0.9 |
| %K %D | K(14,3) : | 60.4 |
D(3) : | 70.1 |
| RSI | RSI(14): 57.2 |
|||
| 52-week | High : | 17.2 | Low : | 8.5 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CARL ] has closed above bottom band by 40.1%. Bollinger Bands are 4.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.9 - 15.99 | 15.99 - 16.07 |
| Low: | 15.15 - 15.26 | 15.26 - 15.37 |
| Close: | 15.43 - 15.6 | 15.6 - 15.75 |
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Sun, 30 Aug 2026
Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Tue, 25 Aug 2026
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com
Tue, 25 Aug 2026
Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat
Thu, 13 Aug 2026
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential Move - Defined Outcome ETF - vinanet.vn
Fri, 07 Aug 2026
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - kalkine.ca
Fri, 07 Aug 2026
Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 27 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 44.4 (%) |
| Held by Institutions | 40.3 (%) |
| Shares Short | 1,380 (K) |
| Shares Short P.Month | 1,310 (K) |
| EPS | -2.34 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.08 |
| Profit Margin | -57.5 % |
| Operating Margin | -58.3 % |
| Return on Assets (ttm) | -28.2 % |
| Return on Equity (ttm) | -66.2 % |
| Qtrly Rev. Growth | 56.7 % |
| Gross Profit (p.s.) | 1.77 |
| Sales Per Share | 2.31 |
| EBITDA (p.s.) | -1.41 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -34 (M) |
| Levered Free Cash Flow | -26 (M) |
| PE Ratio | -6.67 |
| PEG Ratio | 0 |
| Price to Book value | 5.04 |
| Price to Sales | 6.72 |
| Price to Cash Flow | -12.48 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|